Mar 1, 2021|
JD Health Enhances O2O Effort for Parkinson’s Disease
by Vivian Yang
JD Health’s online pharmacy resources will be integrated into the mobile app of Shanghai Huashan Hospital for Parkinson’s disease to improve patients’ accessibility to medication and their overall treatment experience, which was announced on Feb 26 in Shanghai.
The medical platform for Parkinson’s disease is first of its kind in China to integrate online resources in the whole treatment process for Parkinson’s disease, with pharmaceutical services, covering pre-diagnosis, diagnosis and post-diagnosis healthcare management. The project is the joint effort of JD Health, Huashan Hospital affiliated with Fudan University, and German pharmaceutical manufacturer Boehringer-Ingelheim.
The launch ceremony of the medical platform for Parkinson’s disease
In the first stage, the project will be focused on the patient service model developed by Huashan Hospital, which has been a pioneer in the diagnosis and treatment of Parkinson’s disease in China for over 50 years, and began to build its online database platform for the disease’s management in 2011. The platform has evolved over the years into a mobile app known as Pawei(帕为), and an internet-based hub that pools multiple disciplines together in the areas of neurology, neurosurgery, rehabilitation, psychology and more to provide a one-stop service for patients with Parkinson’s disease.
Though patients can make doctor appointment easier through this platform and get the prescriptions, many patients said that they could not find certain medicines in their vicinity.
Under the agreement of this project, Pawei will feature a medicine supply section on its landing page which directs users to JD Health’s online care center for Parkinson’s disease where patients can order medication directly from JD Pharmacy. Patients can find almost all medication available on the Chinese market through this platform and enjoy JD’s same-day or next-day delivery service covering more than 90% of areas in the country.
Valuable knowledge and information about Parkinson’s currently available on Pawei will also be made available on JD Health to further promote and facilitate further education around the disease.
“With the development of telemedicine, managing chronic diseases via online channels has proven to be an effective way to save patients’ hospital visiting time,” noted Dr. Ying Mao, president of Huashan Hospital, at the center launch ceremony.
According to Mao, each year, nearly 12,000 Parkinson’s patients come to Huashan Hospital collectively making a total of 30,000 visits. More than half of the patients are from outside of Shanghai. “I make it so the simple and repetitive tasks can be processed online, such as revisiting doctors and dispensing medication, our limited offline hospital resources can be saved for patients who need them most,” Mao added.
It is estimated that there are about three million patients with Parkinson’s in China, , with a prevalence rate of 1.7% among people over 65 years old. The rate is going up with the aging of the Chinese population. According to the WHO’s estimate, the number of patients with Parkinson’s disease in China will reach 5 million by 2030.
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
Nov 7, 2024|
CIIE 2024: JD.com to Expand Imports of Specialty Brands, Strengthen Healthcare Partnerships, and Enhance Logistics
At the 7th China International Import Expo (CIIE) on November 5, JD Super, the supermarket division of JD.com, announced a major initiative to broaden its selection of imported specialty. Over the next three years, JD Super plans to introduce over 1,000 new international brands to meet the increasing demand for high-quality, diverse imported goods.
Meeting the Growing Demand for Quality Imports
According to JD Worldwide’s “White Paper on 2024 China Cross-Border Consumption Trends,” more than 80% of Chinese consumers are interested in imported products, with many prioritizing authenticity, quality, and fast delivery. In response, JD has significantly expanded its range of international offerings. During the ongoing Singles’ Day Grand Promotion, sales of cross-border products have surged, with more than 600 brands experiencing a sales increase of over 100% compared to last year.
Strengthening High-Quality Food Partnerships
Demonstrating JD.com’s commitment to sourcing high-quality products, JD Super signed a new procurement agreement at CIIE with Huadong Foods and Teys, a major Australian beef brand under Cargill. Under this agreement, JD Super and Huadong Foods will procure $50 million of Teys beef throughout 2025. This partnership underscores JD’s strategy of collaborating with trusted suppliers to provide high-quality, affordable beef to Chinese consumers.
Delivering Authentic Global Goods Efficiently
JD Logistics has built a robust logistics network that spans bonded, direct mail, and overseas warehouses, facilitating fast deliveries of imported items across categories such as electronics, fashion, beauty, food, and baby products. In many major cities, delivery times have been reduced to under 48 hours.
For instance, JD Super’s partnership with Raub of Malaysia enables the import of Musang King durians, which are harvested at peak ripeness and air-shipped with cold chain logistics for delivery within 24 hours. Additionally, JD.com also secured an early supply of Chilean cherries, available since October, which can be delivered in as little as 30 minutes in many areas through JD NOW, its on-demand retail service.
JD.com’s “JD National Pavilions” program, which features over 150 country-themed flagship stores from more than 70 countries and regions, continues to be a cornerstone of its import strategy. Supported by embassies and reputable organizations, this initiative offers Chinese consumers access to premium products and cultural experiences from around the world. In April, JD launched the JD National Pavilion of Mali, introducing popular items like shea butter and garnering over 40,000 followers.
Expanding Healthcare and Logistics Partnerships
JD Health is also making strides at CIIE by strengthening partnerships with leading global healthcare companies, including Merck, Bayer, and Roche. As “China’s premier online health access point,” JD Health is committed to integrating digital and physical healthcare resources to improve access and convenience for patients.
Key collaborations include initiatives with Haleon to promote brain health and anti-aging for the “silver economy,” with MSD China on a digital diabetes management model, and with Teva Pharmaceuticals to provide patient education for conditions such as tardive dyskinesia (TD) and Huntington’s disease (HD).
On the logistics front, JD Logistics announced plans to double its overseas warehouse space by 2025 and expand its network of bonded and direct mail warehouses. JD Express now serves over 60 countries, enhancing cross-border delivery efficiency and supporting both brands and consumers.
Through these efforts, JD.com reaffirms its commitment to sourcing and delivering authentic, high-quality imported products to Chinese consumers, supported by an advanced supply chain that ensures a superior shopping experience.
(vivian.yang@jd.com)
JD Health Establishes Rare Diseases Care Center
